 Leonard Mukasa
Concepts (83)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tuberculosis | 9 | 2024 | 104 | 1.510 |
Why?
| | Mycobacterium tuberculosis | 8 | 2021 | 212 | 1.100 |
Why?
| | Tuberculosis, Pulmonary | 2 | 2018 | 85 | 0.650 |
Why?
| | Transients and Migrants | 1 | 2016 | 27 | 0.560 |
Why?
| | Tuberculosis, Miliary | 1 | 2014 | 3 | 0.510 |
Why?
| | Radiography, Thoracic | 1 | 2014 | 69 | 0.490 |
Why?
| | Lung | 1 | 2014 | 507 | 0.390 |
Why?
| | Leprosy | 2 | 2020 | 6 | 0.340 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 1222 | 0.330 |
Why?
| | Arkansas | 10 | 2024 | 2097 | 0.330 |
Why?
| | Delayed Diagnosis | 1 | 2021 | 25 | 0.200 |
Why?
| | Leprosy, Multibacillary | 1 | 2020 | 5 | 0.190 |
Why?
| | Armadillos | 1 | 2020 | 6 | 0.190 |
Why?
| | Contact Tracing | 2 | 2015 | 8 | 0.190 |
Why?
| | Sputum | 2 | 2018 | 56 | 0.190 |
Why?
| | Adolescent | 8 | 2021 | 6896 | 0.170 |
Why?
| | Cluster Analysis | 2 | 2016 | 244 | 0.160 |
Why?
| | Rural Population | 2 | 2021 | 597 | 0.160 |
Why?
| | Antibiotics, Antitubercular | 1 | 2017 | 14 | 0.160 |
Why?
| | Latent Tuberculosis | 1 | 2017 | 9 | 0.160 |
Why?
| | Isoniazid | 1 | 2017 | 30 | 0.160 |
Why?
| | Rifampin | 1 | 2017 | 57 | 0.150 |
Why?
| | Antitubercular Agents | 1 | 2017 | 90 | 0.150 |
Why?
| | Alcohol Drinking | 1 | 2018 | 259 | 0.140 |
Why?
| | Male | 10 | 2021 | 27335 | 0.130 |
Why?
| | Aged | 8 | 2020 | 10054 | 0.130 |
Why?
| | Female | 10 | 2021 | 28457 | 0.130 |
Why?
| | Young Adult | 6 | 2021 | 4313 | 0.120 |
Why?
| | Genotype | 5 | 2021 | 600 | 0.120 |
Why?
| | Child | 5 | 2021 | 7372 | 0.120 |
Why?
| | Humans | 14 | 2024 | 54304 | 0.110 |
Why?
| | Incidence | 4 | 2024 | 1083 | 0.110 |
Why?
| | Child, Preschool | 3 | 2017 | 4161 | 0.100 |
Why?
| | Diagnosis, Differential | 1 | 2014 | 1143 | 0.100 |
Why?
| | Middle Aged | 8 | 2020 | 13076 | 0.090 |
Why?
| | Host-Pathogen Interactions | 1 | 2011 | 143 | 0.090 |
Why?
| | Infant | 2 | 2016 | 3832 | 0.080 |
Why?
| | Infant, Newborn | 1 | 2016 | 2923 | 0.080 |
Why?
| | Adult | 7 | 2021 | 14189 | 0.080 |
Why?
| | Type C Phospholipases | 1 | 2005 | 15 | 0.070 |
Why?
| | DNA Transposable Elements | 1 | 2005 | 82 | 0.070 |
Why?
| | Polymorphism, Genetic | 1 | 2005 | 193 | 0.060 |
Why?
| | Gene Deletion | 1 | 2005 | 293 | 0.060 |
Why?
| | Risk Factors | 4 | 2018 | 3934 | 0.060 |
Why?
| | Minority Groups | 1 | 2024 | 136 | 0.060 |
Why?
| | Age Factors | 2 | 2018 | 1200 | 0.050 |
Why?
| | Mycobacterium leprae | 1 | 2020 | 7 | 0.050 |
Why?
| | Soil Microbiology | 1 | 2020 | 23 | 0.050 |
Why?
| | Micronesia | 1 | 2020 | 118 | 0.050 |
Why?
| | Disease Outbreaks | 1 | 2021 | 124 | 0.050 |
Why?
| | Aged, 80 and over | 2 | 2020 | 3430 | 0.040 |
Why?
| | Comorbidity | 1 | 2021 | 666 | 0.040 |
Why?
| | Alcoholism | 1 | 2021 | 249 | 0.040 |
Why?
| | Biopsy | 1 | 2020 | 693 | 0.040 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2021 | 552 | 0.040 |
Why?
| | Molecular Epidemiology | 2 | 2011 | 36 | 0.040 |
Why?
| | Skin | 1 | 2020 | 468 | 0.040 |
Why?
| | Drug Administration Schedule | 1 | 2017 | 401 | 0.040 |
Why?
| | Multivariate Analysis | 1 | 2018 | 643 | 0.040 |
Why?
| | Drug Therapy, Combination | 1 | 2017 | 426 | 0.030 |
Why?
| | Students | 1 | 2017 | 207 | 0.030 |
Why?
| | Logistic Models | 1 | 2018 | 991 | 0.030 |
Why?
| | Public Health Surveillance | 1 | 2014 | 13 | 0.030 |
Why?
| | Models, Theoretical | 1 | 2015 | 184 | 0.030 |
Why?
| | Age Distribution | 1 | 2014 | 198 | 0.030 |
Why?
| | Pilot Projects | 1 | 2016 | 805 | 0.030 |
Why?
| | Urban Population | 1 | 2014 | 182 | 0.030 |
Why?
| | Prevalence | 1 | 2015 | 1026 | 0.030 |
Why?
| | Sex Factors | 1 | 2014 | 766 | 0.020 |
Why?
| | HIV Seropositivity | 1 | 2011 | 28 | 0.020 |
Why?
| | Interdisciplinary Communication | 1 | 2011 | 64 | 0.020 |
Why?
| | Genetic Variation | 1 | 2011 | 253 | 0.020 |
Why?
| | United States | 1 | 2017 | 5204 | 0.020 |
Why?
| | Mutagenesis, Insertional | 1 | 2005 | 28 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2005 | 274 | 0.020 |
Why?
| | Animals | 1 | 2020 | 14402 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2005 | 980 | 0.010 |
Why?
| | DNA Fingerprinting | 1 | 2002 | 38 | 0.010 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 2002 | 44 | 0.010 |
Why?
| | Maryland | 1 | 2002 | 34 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 2005 | 456 | 0.010 |
Why?
| | Socioeconomic Factors | 1 | 2002 | 638 | 0.010 |
Why?
| | Time Factors | 1 | 2002 | 3207 | 0.010 |
Why?
|
|
Mukasa's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|